CORD-19:dc97e1de3b69da13f534f15afdcedbf48064c69d / 627258-627788 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/dc97e1de3b69da13f534f15afdcedbf48064c69d","sourcedb":"CORD-19","sourceid":"dc97e1de3b69da13f534f15afdcedbf48064c69d","text":"To treat toxicity, administer activated charcoal, intravenous fluids to promote diuresis and treat hyperthermia, chlorpromazine to combat α-adrenergic effects, a β-blocker (propranolol, 0.04 to 0.1 mg/kg IV slowly to effect; esmolol, 50 to 100 mcg/kg IV bolus, 50 to 200 mcg/kg/min IV CRI; atenolol, 0.5 to 1 mg/kg PO q12h [canine], 6.25 to 12.5 mg/cat PO q12-24h [feline]) to treat β-adrenergic effects, and cyproheptadine (0.5 to 1.1 mg/kg POq12h or per rectum dog, 2 mg/k cat PO or per rectum) to combat serotoninergic effects.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T36097","span":{"begin":0,"end":530},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T36097","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T408","span":{"begin":0,"end":530},"obj":"Sentence"}],"attributes":[{"subj":"T408","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T3121","span":{"begin":99,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A3121","pred":"hp_id","subj":"T3121","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"subj":"T3121","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2574","span":{"begin":456,"end":462},"obj":"Body_part"},{"id":"T2575","span":{"begin":489,"end":495},"obj":"Body_part"}],"attributes":[{"id":"A2574","pred":"uberon_id","subj":"T2574","obj":"http://purl.obolibrary.org/obo/UBERON_0001052"},{"id":"A2575","pred":"uberon_id","subj":"T2575","obj":"http://purl.obolibrary.org/obo/UBERON_0001052"},{"subj":"T2574","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T2575","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93e9","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ecd5"},{"id":"CORD-19-PD-HP","color":"#ecbb93"},{"id":"CORD-19-PD-UBERON","color":"#a193ec"}]}]}}